Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer
- 11 July 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 264 (2) , 213-217
- https://doi.org/10.1001/jama.264.2.213
Abstract
Research from JAMA — Eosinophilia-Myalgia Syndrome Associated With Exposure to Tryptophan From a Single ManufacturerThis publication has 7 references indexed in Scilit:
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- L-tryptophan and eosinophilia-myalgia syndrome in New MexicoThe Lancet, 1990
- A Case of the Eosinophilia-Myalgia Syndrome Associated with Use of an L-Tryptophan ProductAnnals of Internal Medicine, 1990
- Interim Guidance on the Eosinophilia-Myalgia SyndromeAnnals of Internal Medicine, 1990
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983
- Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1980